Susannah Luthi

Congress has to get along to pass controversial healthcare policies badly wanted by voters: but will impeachment get in the way?

While the 11th Circuit ruled that HHS followed the required procedures to make the liver allocation changes, it asked a federal district court to look at additional legal questions in the lawsuit.

Impeachment politics and partisan policy disagreements seem likely to derail drug pricing legislation, and Senate Finance Committee Chair Chuck Grassley acknowledged a legislative deal may slip into next year.

Plaintiffs who want an appellate court to put the Trump administration's Title X regulations on hold faced a skeptical bench in the 9th U.S. Circuit Court of Appeals.

The U.S. House of Representatives passed a temporary funding bill that stalls the Medicaid DSH debate until Nov. 21.

House Speaker Nancy Pelosi's proposal to lower drug prices intensifies two major provisions drugmakers hate: international reference pricing and inflation caps.

Hospitals scored a big court win on site-neutral payments, but people who want to see payment reform warn that the issue isn't going away.

Lawmakers who want changes to the Medicaid DSH program still hope to negotiate some reforms, but the continuing resolution would secure hospitals' first-quarter payments, which are distributed by the states.

A federal judge ruled that HHS exceeded its authority when it cut rates for basic visits at off-campus hospitals, handing a win to providers.

Tennessee is promising hospitals they can share savings from a proposed Medicaid block grant program, but patient advocates are skeptical.

Lawmakers are investigating private equity-backed physician-staffing companies to determine whether they use out-of-network billing as a strategy to drive up their pay rates, the latest missive in the surprise medical bill fight.

For the first time since President Donald Trump took office, both parties are mostly united in wanting to attack the practice of surprise billing and drug prices. But can they deliver?

The lawsuit fits into the legal battle that providers have been waging for years against the largest behavioral health plan in the country, as United Behavioral Health allegedly denied medically necessary treatment claims.

A leaked draft plan from House Speaker Nancy Pelosi (D-Calif.) to lower drug prices through negotiation puts more pressure on the pharmaceutical lobby ahead of an expected year-end deal.

The Senate's HHS appropriations bill adds strings to its funding for the nation's organ transplant system.